Standalone SPECT nuclear imaging

Single-photon emission computed tomography (SPECT) is a nuclear tomographic imaging technique that uses gamma rays to diagnose and monitor various disorders such as those of the brain, heart, and bone. A SPECT scan controls the level of biological activity to acquire 3D images from multiple angles.


“SPECT nuclear imaging technique is used for various applications such as to diagnose conditions of the central nervous system, in radiosurgery, for the treatment of intracranial tumors, arteriovenous malformations, and other surgical procedures. The adoption rate for SPECT is increasing, due to the high cost of PET scanners,” adds Barath.

Hybrid nuclear imaging

Hybrid nuclear imaging is an excellent diagnostic tool in the modern-day medicine used for multiple therapeutic applications. Hybrid nuclear imaging involves the fusion of different diagnostic imaging products such as PET/CT, PET/MRI, PET/SPECT, SPECT/CT, and SPECT/MRI which allows correlation between anatomical and functional imaging.

SPECT/CT hybrid nuclear imaging has proven valuable for oncology. These hybrid nuclear imaging modalities have potential to aid the develop personalized molecular medicine. These technologies will aid in detecting and evaluating various disorders such as cardiology, oncology, and neurology.

The top vendors highlighted by Technavio’s research analysts in this report are:

Digirad
GE Healthcare
Mediso
Koninklijke Philips
Siemens Healthcare

Back to HCB News

Molecular Imaging Homepage